Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Fuji
Farmers Insurance
Boehringer Ingelheim
McKesson
Express Scripts

Generated: May 24, 2019

DrugPatentWatch Database Preview

Litigation Details for Novo Nordisk A/S v. Caraco Pharmaceutical Laboratories, Limited (E.D. Mich. 2005)

« Back to Dashboard

Novo Nordisk A/S v. Caraco Pharmaceutical Laboratories, Limited (E.D. Mich. 2005)

Docket ➤ Sign Up Date Filed 2005-06-09
Court District Court, E.D. Michigan Date Terminated 2014-03-19
Cause No cause code entered Assigned To Avern Levin Cohn
Jury Demand Defendant Referred To Donald a. Scheer
Parties CARACO PHARMACEUTICAL LABORATORIES, LIMITED; GRAUER; NOVO NORDISK A/S; NOVO NORDISK, INCORPORATED; SUN PHARMACEUTICAL INDUSTRIES, LIMITED
Patents 6,677,358
Attorneys Charles B. Klein; David S. Bloch; Eric S. Goldstein; Herschel P. Fink; J. Michael Huget; James F. Hunt; John L. LaBarre - INACTIVE; Joseph R. Robinson; Josh A. Krevitt; Michael A. Sitzman; Michelle L. Alamo; Morley Witus; Richard D. Grauer; Robert C. Sullivan - INACTIVE , Jr.; Robert Schaffer; Steven E. Lipman
Firms Barris, Sott, Denn & Driker, PLLC; City of Livonia, Department of Law; Darby & Darby, PC; Detroit Free Fress; Dickinson Wright; Gibson Dunn Crutcher LLP; Gibson, Dunn; Honigman Miller Schwartz and Cohn LLP; Johnston, Sztykiel, Hunt, Goldstein, Fitzgibbons & Clifford,; Richard D. Grauer; Winston & Strawn LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Novo Nordisk A/S v. Caraco Pharmaceutical Laboratories, Limited
The small molecule drugs covered by the patent cited in this case are ➤ Sign Up and ➤ Sign Up .

Details for Novo Nordisk A/S v. Caraco Pharmaceutical Laboratories, Limited (E.D. Mich. 2005)

Date Filed Document No. Description Snippet Link To Document
2009-08-31 371 Memorandum Opinion & Order Repaglinide United States Patent Number: U.S. 6,677,358 B1 Patent Claim Number: 4 …repaglinide/metformin HCl United States Patent Number: U.S. 6,677,358 Patent Claim Number: 4… Repaglinide United States Patent Number: U.S. 6,677,358 Patent Claim Number: 4… use code relating to U.S. Patent No. 6,677,358 to correspond with the change in labeling… present use code relating to U.S. Patent No. 6,677,358. Applicant believes the use External link to document
2009-09-11 384 Declaration File History to the Application for U.S. Patent No. 6,677,358, # 4 Exhibit Exhibit J - Copy of Presentation…2005 19 March 2014 2:05-cv-40188 830 Patent Defendant District Court, E.D External link to document
2009-09-11 400 Sealed Exhibit of Domenico Accili, M.D. Concerning U.S. Patent No., 6,677,358 - Under Seal re 384 Declaration,, by Sun…2005 19 March 2014 2:05-cv-40188 830 Patent Defendant District Court, E.D External link to document
2009-09-24 421 Order on Sealed Motion ANDA to “submit an updated patent certification addressing the 6,677,358 patent and its associated Use …ID 8436 020741 001 6,677,358 06/12/2018 U-9682 020741 001 …PRANDIN Patent Data Appl. No. Prod. No. Patent No. Patent Patent … covers repaglinide. The ‘358 patent which is the subject of this patent action does not cover repaglinide…repaglinide is not covered by the ‘358 patent: “[T]he ‘358 patent contains 5 claims one of which (claim External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Express Scripts
Queensland Health
Farmers Insurance
McKinsey
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.